BioSpace · 3 days ago
Research Scientist, Antibody Discovery & Engineering, In Vivo Based Methods
Wonder how qualified you are to the job?
Maximize your interview chances
BiotechnologyCommunities
Comp. & Benefits
Insider Connection @BioSpace
Responsibilities
Draw on expertise from in vivo based discovery platforms to provide guidance on strategies towards candidate profiles for differing target types.
Design and execute immunization strategies including guidance on best immunogen, adjuvant, and immunization routes.
Perform animal tissue harvest, B cell separation, and refined enrichment techniques for antigen-specific antibody screening.
Collaborate with high-throughput mammalian expression teams for downstream tasks.
Prepare and present technical/project reports to internal/external audiences.
Interface with cross functional teams and remain aware of the competitive landscape.
Contribute to strategies for biologics discovery and engineering.
Set high standards for effectiveness, efficiency, and rigor of thought.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
PhD degree in a scientific discipline (or equivalent), or MS with 6+ years relevant experience, or BS with 8+ years relevant experience.
Demonstrates theoretical knowledge of discipline in the field of in vivo antibody-based antibody discovery.
Keeps current with emerging trends in discipline.
Benefits
Medical insurance
Dental insurance
Vision insurance
401(k) plan with company match
Short-term and long-term disability coverage
Basic life insurance
Tuition reimbursement program
Paid volunteer time off
Company holidays
Well-being benefits
Up to 80 hours of sick time per calendar year
Up to 120 hours of paid vacation for new hires
Company
BioSpace
BioSpace is the leading online community for industry news and careers for life science professionals.
Funding
Current Stage
Growth StageTotal Funding
$10M2000-08-24Series B· $10M
Recent News
2024-05-31
2024-05-05
2024-04-06
Company data provided by crunchbase